Psychologists in Garner, NC Accepting Medicare
7 Psychologists found. Showing 1 - 7
 Dr. Alice Hasty Verstrat, PHD Psychologist - Health Service Medicare: Not Enrolled in Medicare Practice Location: 1201 Aversboro Rd Ste C, Garner, NC 27529 Phone: 919-335-7595 Fax: 919-779-4223 |
 Mr. John H Blackshear, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 149 Us Highway 70 W, Garner, NC 27529 Phone: 919-329-6001 Fax: 919-662-7883 |
Ms. Elizabeth Ann Kauff-hill, M.A. Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 109 Professional Ct, Suite 105, Garner, NC 27529 Phone: 919-662-3757 Fax: 919-662-3765 |
Lesley Graham, PSY.D Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 146 Donmoor Ct, Garner, NC 27529 Phone: 919-662-9517 Fax: 919-662-9515 |
Dr. David Archie Norris, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 223 Hwy 70 East, 220 W Millbrook Rd Ste 130, Garner, NC 27529 Phone: 919-772-9371 Fax: 919-779-6999 |
Dr. Ronald J Valentine, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1201 Aversboro Rd, Suite C, Garner, NC 27529 Phone: 919-779-3188 Fax: 919-779-4223 |
Dr. Yesenia Schuler, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 66 Brakas Ln, Garner, NC 27529 Phone: 603-455-7768 |
News Archive
Novel approach to kill acute lymphoblastic leukemia cells
Nora Heisterkamp, PhD, and Reshmi Parameswaran, PhD, of The Saban Research Institute of Children's Hospital Los Angeles, have found a novel approach to killing acute lymphoblastic leukemia (ALL) cells. Using a fusion toxin that specifically targets cancer cells, this novel therapeutic may offer a future alternative to patients who become resistant to chemotherapy.
iPierian announces closing of $22M Series B equity financing round
iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.
Cancer cure worth $50 trillion
A new study, to be published in a forthcoming issue of the Journal of Political Economy, calculates the prospective gains that could be obtained from further progress against major diseases.
Boston Globe examines rise of polio in Tajikistan, other pockets of world
"Polio has reappeared in a corner of the world that had not seen cases in years - Tajikistan, the former Soviet republic - a chilling setback in the two-decade campaign to purge a dreaded cause of childhood paralysis from the planet," the Boston Globe reports in a story that examines the reemergence of polio in other areas of the world.
Alnylam reports further progress on broadening the therapeutic potential of RNAi
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today further progress on the Company's platform efforts in extrahepatic delivery of novel siRNA conjugates, including central nervous system (CNS) and ocular delivery in rat and non-human primates (NHPs).
› Verified 9 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists
Psychologists